Manufacturing Update: China’s Made in China 2025+ Strategy Shift
China’s Made in China 2025+ (中国制造2025+, Zhongguo zhizao 2025+) strategy shift represents a recalibrated industrial roadmap targeting 70% domestic self-sufficiency in core advanced manufacturing components by 2028—up from approximately 45% in 2020. This updated directive, emerging from the 2024 Central Economic Work Conference and subsequent policy documents, signals a more aggressive push for technological sovereignty while adapting to intensifying global trade restrictions. For foreign executives, this shift fundamentally reshapes market access conditions, supply chain architecture, and partnership models across China’s $4.5 trillion manufacturing sector.
Why This Matters
The Made in China 2025+ recalibration is not a minor policy adjustment—it is a structural reorientation of the world’s largest manufacturing economy. Foreign companies that previously supplied critical components, industrial software, or precision machinery to Chinese buyers now face three converging pressures: rising domestic替代 (替代, tidài, substitution) requirements, stricter data and technology transfer rules, and accelerated state-backed R&D spending that is compressing the technology gap faster than many anticipated. Understanding the specific targets, timelines, and sector priorities within the updated framework is essential for any foreign executive with production, sourcing, or sales operations tied to China.
The Evolution: From Made in China 2025 to 2025+
The original Made in China 2025 (中国制造2025, Zhongguo zhizao 2025), unveiled in 2015, set a 10-year horizon for upgrading China’s manufacturing base across 10 priority sectors. By 2023, independent assessments showed partial progress: China achieved self-sufficiency targets in sectors like high-speed rail (85% domestic content) and power equipment (78%), but lagged significantly in semiconductors (self-sufficiency estimated at 16%), advanced machine tools (35%), and industrial software (30%).
- Phase One (2015–2020): Foundation building—state subsidies, technology acquisition through joint ventures, and initial domestic substitution in low-to-mid-tier components. Foreign-invested enterprises retained significant market share in high-end segments.
- Phase Two (2021–2024): Acceleration under the 14th Five-Year Plan—doubling of R&D tax incentives, creation of National Manufacturing Innovation Centers, and stricter localization requirements for government procurement. Foreign WFOEs (外商独资企业, waishang duzi qiye) faced growing pressure to transfer advanced processes.
- Phase Three (2025+): The recalibrated strategy—explicit national security framing, emphasis on “indigenous innovation” (自主创新, zìzhǔ chuàngxīn), and a shift from broad industrial policy to targeted breakthroughs in 20 “bottleneck” technology areas.
Key difference in the 2025+ version: The original plan emphasized market share targets. The updated framework prioritizes technology maturity and supply chain resilience, reflecting lessons from the US-China technology war and COVID-era supply disruptions.
Key Target Sectors Under the Updated Plan
The Made in China 2025+ strategy identifies 20 “critical technology clusters” with specific self-sufficiency and investment targets. Below are the five highest-priority clusters:
| Sector | 2024 Domestic Self-Sufficiency | 2028 Target | State Investment (2025–2027) |
|---|---|---|---|
| Advanced Semiconductor Manufacturing (7nm and below) | ~12% | 35% | CNY 420 billion ($58B) |
| Industrial Robotics (high-precision, 6-axis+) | ~38% | 65% | CNY 180 billion ($25B) |
| Aerospace Engines & Components | ~42% | 60% | CNY 210 billion ($29B) |
| Medical Devices (high-end imaging, implants) | ~45% | 70% | CNY 95 billion ($13B) |
| Industrial Software (CAD/CAM/PLM) | ~28% | 50% | CNY 120 billion ($17B) |
These targets represent a significant acceleration. For context, China’s semiconductor self-sufficiency rate grew only 4 percentage points between 2020 and 2024. The new plan implies nearly 6 percentage points of annual improvement—a pace that will require unprecedented capital deployment and technology breakthroughs.
Implementation Mechanisms: How Beijing Will Enforce the Shift
The strategy is not voluntary. Foreign enterprises should understand the key implementation tools:
- Government Procurement Preferences: All provincial and central government tenders for manufacturing equipment, software, and services now include a mandatory “domestic innovation scoring” component. Products certified as “indigenous” (国产, guóchǎn) receive a 15–25% price preference in evaluation formulas.
- Technology Transfer Requirements: New WFOE manufacturing projects in designated priority sectors must submit technology roadmaps demonstrating phased localization of critical subcomponents. This applies to both greenfield investments and expansion projects.
- State-Owned Enterprise (国企, guóqǐ) Mandates: SOEs in the manufacturing supply chain are required to achieve annual domestic procurement growth of at least 12% through 2028, with quarterly reporting to the State-owned Assets Supervision and Administration Commission (SASAC).
- R&D Super Deduction: The corporate income tax super deduction for eligible R&D expenditure has been raised from 100% to 150% for activities aligned with the 20 “bottleneck” technology areas—effectively reducing the after-tax cost of qualifying R&D by up to 37.5%.
- National Manufacturing Fund II: A CNY 300 billion ($41.5B) fund launched in early 2025 provides equity co-investment for foreign and domestic firms that meet technology transfer and joint development benchmarks.
Impact on Foreign Enterprises: A Shifting Landscape
The practical implications for foreign manufacturing companies operating in or exporting to China are significant:
- Market Access Tightening: At least three provincial governments have introduced informal “technology sovereignty” review boards that assess whether foreign-invested projects align with Made in China 2025+ goals. Projects deemed to compete with domestic champions face delays or rejection.
- Supply Chain Repositioning: Foreign suppliers of high-end components are seeing Chinese buyers demand joint development agreements (JDAs) rather than standard purchase orders. In a survey by the American Chamber of Commerce in China (February 2025), 68% of member companies reported pressure to transfer some form of intellectual property.
- New Partnership Models: The National Manufacturing Fund II explicitly requires that co-invested projects establish a “technology co-development structure” between foreign partners and Chinese entities. This is driving adoption of structured joint ventures (合资企业, hézī qǐyè) with defined IP contribution frameworks.
- Competitive Intensity: Chinese domestic competitors are closing the technology gap faster than many expected. In industrial robotics, for example, domestic market share among top-tier Chinese firms (such as Estun Automation and Inovance) has grown from 28% in 2020 to an estimated 44% in 2025—approaching the trajectory set by the plan.
Key Statistic to Watch: China’s total manufacturing R&D spending reached an estimated CNY 2.8 trillion ($387B) in 2024, representing 2.6% of manufacturing value added. The 2025+ plan targets 3.1% by 2028—a level that would bring China close to Germany’s current ratio and significantly above the US manufacturing R&D intensity (approximately 2.0%).
Critical Pitfalls in the New Landscape
Foreign executives face three categories of risk that require immediate attention:
1. Overestimating the Timeline
Many foreign companies assume the 2028 targets are aspirational and that actual implementation will be delayed. This is a dangerous assumption. Provinces with large manufacturing bases (Guangdong, Jiangsu, Zhejiang) have already cascaded national targets into provincial assessment systems for both government officials and state-owned enterprises. Quarterly progress reports are being reviewed at the Central level. The enforcement intensity is higher than during 2015–2020.
2. Misjudging IP Risk in Joint Development
The new co-development structures encouraged by the National Manufacturing Fund II carry heightened IP leakage risk. Several recent cases, including a German precision machinery firm and a Japanese advanced materials company, have reported that Chinese partners in structured JVs used co-developed technology for competing products within 18 months. Due diligence on background IP separation and field-of-use restrictions is now essential, not optional.
3. Underestimating Compliance Burden
The Made in China 2025+ framework introduces new reporting obligations for foreign-invested manufacturing companies. These include annual technology localization progress reports, domestic procurement declarations, and R&D expenditure classifications. Non-compliance can result in exclusion from government procurement, loss of tax incentives, and in extreme cases, revocation of business licenses for manufacturing WFOEs. The administrative burden has increased by an estimated 30–40% year-on-year since 2023.
Strategic Adaptations for Foreign Executives
While the risks are real, opportunities remain for foreign companies that adapt effectively:
- Position as a Technology Partner: Firms that frame their China operations as contributing to “shared innovation” (协同创新, xiétóng chuàngxīn) rather than purely as export platforms receive more favorable regulatory treatment. Several European industrial automation companies have successfully positioned their China R&D centers as integral to achieving Made in China 2025+ targets.
- Leverage the National Manufacturing Fund II: The fund is actively seeking foreign partners for co-investment in bottleneck technology areas. While participation requires technology sharing, the fund’s matching capital (up to 30% of project costs) and regulatory facilitation can offset risks—particularly if the IP contribution is carefully structured.
- Focus Aftermarket and Services: Even as China pushes domestic substitution in hardware and software, demand for specialized engineering services, training, and maintenance remains strong. Foreign firms can often operate in these adjacent segments with less IP exposure.
Where to Go From Here
For foreign executives making decisions about China manufacturing operations in the context of this strategy shift, we recommend the following decision-path approach:
- Audit Your Sector Exposure Immediately: Map your product lines and technologies against the 20 “bottleneck” areas designated under Made in China 2025+. If your core offerings fall into these categories (particularly semiconductors, robotics, medical devices, or industrial software), commission a technology localization readiness assessment within 90 days. Understand which components of your value chain can be replicated domestically and which remain dependent on foreign expertise.
- Evaluate the Co-Development Option vs. Export Restructuring: For companies currently exporting high-end manufacturing inputs to China, decide within the next 6 months whether to establish a structured onshore co-development arrangement or restructure the export model to serve non-Chinese markets preferentially. The regulatory landscape continues to tighten, and a wait-and-see approach risks loss of both market access and negotiating leverage.
- Review Your China Entity Structure: For firms operating through WFOEs, assess whether your current entity type and IP protection framework are adequate for the 2025+ environment. Consider whether migrating to a structured joint venture with a state-affiliated partner—with clear IP contribution and field-of-use boundaries—provides better long-term positioning than maintaining a fully-owned entity that faces growing localization pressure.
These three paths are not mutually exclusive; many companies will pursue elements of all three as part of a phased China manufacturing strategy. The key is to make conscious choices rather than allowing the shifting regulatory environment to make them for you.
